Compare XERS & KDK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XERS | KDK |
|---|---|---|
| Founded | 2005 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2018 | N/A |
| Metric | XERS | KDK |
|---|---|---|
| Price | $7.92 | $9.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | $10.43 | ★ $15.63 |
| AVG Volume (30 Days) | ★ 2.5M | 1.1M |
| Earning Date | 11-06-2025 | 02-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $266,137,000.00 | $16,450,000.00 |
| Revenue This Year | $44.37 | $4,295.10 |
| Revenue Next Year | $27.87 | $295.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 42.05 | N/A |
| 52 Week Low | $3.14 | $5.43 |
| 52 Week High | $10.08 | $11.62 |
| Indicator | XERS | KDK |
|---|---|---|
| Relative Strength Index (RSI) | 59.42 | N/A |
| Support Level | $6.88 | N/A |
| Resistance Level | $8.42 | N/A |
| Average True Range (ATR) | 0.43 | 0.00 |
| MACD | 0.10 | 0.00 |
| Stochastic Oscillator | 70.38 | 0.00 |
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
Kodiak AI Inc is engaged in the commercial trucking industry and the public sector, based on AI-powered autonomous vehicle technology.